Showing results (1871-1880 of 2,171) with videos related to
Sort By:
Pageof 218
European Heart Journal|April 14, 2006
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL studyAbhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, et al.Journal of Clinical Microbiology|May 16, 2014
Diarrhea burden due to natural infection with enterotoxigenic Escherichia coli in a birth cohort in a rural Egyptian communityA Mansour, H I Shaheen, M Amine, et al.JAMA Dermatology|August 21, 2024
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical TrialApril W Armstrong, Melinda Gooderham, Charles Lynde, et al.Clinical Cardiology|May 14, 2016
Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS TrialEmil Hagström, Matthew T Roe, Gail Hafley, et al.Journal of Cardiac Failure|December 1, 2009
Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluationMark E Patterson, William C Grant, Seth W Glickman, et al.Journal of Internal Medicine|September 30, 2017
Psychosocial stress and major cardiovascular events in patients with stable coronary heart diseaseE Hagström, F Norlund, A Stebbins, et al.The American Journal of Cardiology|May 30, 1998
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary ArteriesJ Hochrein, F Sun, K S Pieper, et al.Journal of the American College of Cardiology|February 11, 2003
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patientsPadma Kaul, L Kristin Newby, Yuling Fu, et al.Journal of the American College of Cardiology|July 4, 2006
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trialMichael P Hudson, Paul W Armstrong, Witold Ruzyllo, et al.Circulation. Cardiovascular Quality and Outcomes|September 1, 2020
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without RevascularizationGuillaume Marquis-Gravel, Megan L Neely, Marco Valgimigli, et al.Pageof 218